dafpus
DESCRIPTION
ihTRANSCRIPT
1. World Health Organization (2012). Dementia A Public Health Priority. (World Health Organization).
2. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Hendrie H, et al.
Global prevalence of dementia: a Delphi consensus study. Lancet. 2005
December 17; 366(9503): 2112–2117.
3. Pendahuluan1 = Ladecola C. The pathobiology of vascular dementia. Neuron. 2013 November 20;80:844-866.
4. 2= Kalaria RN, Path FRC. Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lance Neurol. 2008 September;7(9):812-826.
5. Riskfact= Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia incidence and risk factors in the canadian study of health and aging. Stroke. July 2000;31:1487-1493.
6. Treatment = Levine DA, Langa KM. Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics. 2011;8:361-373.
7. 9= Thal DR, Grinberg LT. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol. 2012 November;47(11):816-824.
8. 10= Lee Y. Vascular dementia. Chonnam Med J. 2011;47:66-71.9. Vci=Bowler JV. Vascular cognitive impairment. J Neurol Neurosurg
Psychiatry 2005;76:35-44.10. Iemolo F, Duro G, Rizzo C, Castiglia L, Hachinski V, Caruso C.
Pathophysiology of vascular dementia. Immun Ageing. 2009;6(13):1-9.11. 3=Korczyn AD, Vakhapova V, Grinberg LT. Vascular dementia. J Neurol Sci.
2012 November 15;322(1-2):2-10.12. 12=Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S. Cognitive assessments for
the early diagnosis of dementia after stroke. Neuropsych Dis Treat. 2014;10:1743-1751.
13. 6= McVeigh C, Passmore P. Vascular dementia: prevention and treatment. Clin Interv Aging. 2006;1(3):229-235.
14. Bowler JV. Modern concept of vascular cognitive impairment. Brit Med Bull. 2007;83:291-305.
15. Buku 3dewa=16. 5=Baskys A, Hou AC. Vascular dementia: pharmacological treatment
approaches and perspectives. Clin Interv Aging. 2007;2(3):327-335.17. Memantin=Lopez-Valdes HE, Clarkson AN, Ao Y, Charles AC, Carmichael
ST, Sofroniew MV, Brennan KC. Memantine enhances recovery from stroke. Stroke. 2014;45:2093-2100.
18. Dichgans M, Markus HS, Salloway S, dkk. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol. 2008;7:310-318.